Severance Hospital, Yonsei University College of Medicine
Severance Hospital, Yonsei University College of Medicine
Seoul, South Korea3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Extrahepatic Cholangiocarcinoma, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract disorder, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm | Recruiting | Not applicable | 2026-01-13 | NCT07235007 | |
| Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Active, not recruiting | Phase 3 | 2025-11-19 | NCT06290349 | |
| Effect of Ezetimibe on Gut Microbiota | Atherosclerotic Cardiovascular Disease With Dyslipidemia | Recruiting | Phase 4 | 2025-01-20 | NCT06784557 |